Lv11
28 积分 2022-04-28 加入
Obinutuzumab in patients with Sjogren’s disease immunised against rituximab
3天前
已完结
Systemic sclerosis in adults. Part I: Clinical features and pathogenesis
4天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
4天前
已完结
Long-term Outcomes After Rituximab Treatment for Patients With Systemic Sclerosis
5天前
已完结
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
5天前
已完结
Proliferative features of IgG4-related disease
14天前
已完结
CAR T Cells and T-Cell Therapies for Cancer
14天前
已完结
Systemic Lupus Erythematosus
14天前
已完结
Systemic lupus erythematosus
14天前
已完结
Development and initial validation of a damage index (DIAPS) in patients with thrombotic antiphospholipid syndrome (APS)
24天前
已完结
皖公网安备34019202002308
